Search

Novonesis (Novozymes) B

Open

407.6 2.23

Overview

Share price change

24h

Current

Min

396

Max

411.8

Key metrics

By Trading Economics

Income

3.6M

242M

Sales

-4.8B

2B

Profit margin

12.084

EBITDA

1.1B

Dividends

By Dow Jones

Next Earnings

8 maj 2025

Novonesis (Novozymes) B Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 lut 2025, 06:51 UTC

Acquisitions, Mergers, Takeovers

DSM-Firmenich to Sell Feed Enzymes Alliance JV Share to Partner for $1.55 Billion

11 lut 2025, 06:15 UTC

Acquisitions, Mergers, Takeovers

Dsm-firmenich Expects to Receive EUR1.4B Net in Cash From Sale

11 lut 2025, 06:15 UTC

Acquisitions, Mergers, Takeovers

Dsm-firmenich Selling Stake for EUR1.5B

11 lut 2025, 06:14 UTC

Acquisitions, Mergers, Takeovers

dsm-firmenich to Sell Stake in Feed Enzymes Alliance to Novonesis

Novonesis (Novozymes) B Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Novonesis (Novozymes) B

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.